N-(4Z-7Z-10Z-13Z-16Z-19Z)-docosahexaenoylethanolamine and Neuralgia

N-(4Z-7Z-10Z-13Z-16Z-19Z)-docosahexaenoylethanolamine has been researched along with Neuralgia* in 3 studies

Other Studies

3 other study(ies) available for N-(4Z-7Z-10Z-13Z-16Z-19Z)-docosahexaenoylethanolamine and Neuralgia

ArticleYear
Anti-Inflammatory Activity of Synaptamide in the Peripheral Nervous System in a Model of Sciatic Nerve Injury.
    International journal of molecular sciences, 2023, Mar-27, Volume: 24, Issue:7

    N-docosahexaenoylethanolamine (DHEA), or synaptamide, is an endogenous metabolite of docosahexaenoic acid (DHA) that exhibits synaptogenic and neurogenic effects. In our previous studies, synaptamide administration inhibited the neuropathic pain-like behavior and reduced inflammation in the central nervous system following sciatic nerve injury. In the present study, we examine the effect of synaptamide on the peripheral nervous system in a neuropathic pain condition. The dynamics of ionized calcium-binding adapter molecule 1 (iba-1), CD68, CD163, myelin basic protein, and the production of interleukin 1β and 6 within the sciatic nerve, as well as the neuro-glial index and the activity of iba-1, CD163, glial fibrillary acidic protein (GFAP), neuronal NO synthase (nNOS), substance P (SP), activating transcription factor 3 (ATF3) in the dorsal root ganglia (DRG), are studied. According to our results, synaptamide treatment (4 mg/kg/day) (1) decreases the weight-bearing deficit after nerve trauma; (2) enhances the remyelination process in the sciatic nerve; (3) shows anti-inflammatory properties in the peripheral nervous system; (4) decreases the neuro-glial index and GFAP immunoreactivity in the DRG; (5) inhibits nNOS- and SP-ergic activity in the DRG, which might contribute to neuropathic pain attenuation. In general, the current study demonstrates the complex effect of synaptamide on nerve injury, which indicates its high potential for neuropathic pain management.

    Topics: Anti-Inflammatory Agents; Ethanolamines; Ganglia, Spinal; Humans; Hyperalgesia; Neuralgia; Sciatic Nerve; Sciatic Neuropathy

2023
Synaptamide Improves Cognitive Functions and Neuronal Plasticity in Neuropathic Pain.
    International journal of molecular sciences, 2021, Nov-26, Volume: 22, Issue:23

    Neuropathic pain arises from damage or dysfunction of the peripheral or central nervous system and manifests itself in a wide variety of sensory symptoms and cognitive disorders. Many studies demonstrate the role of neuropathic pain-induced neuroinflammation in behavioral disorders. For effective neuropathic pain treatment, an integrative approach is required, which simultaneously affects several links of pathogenesis. One promising candidate for this role is synaptamide (N-docosahexaenoylethanolamine), which is an endogenous metabolite of docosahexaenoic acid. In this study, we investigated the activity of synaptamide on mice behavior and hippocampal plasticity in neuropathic pain induced by spared nerve injury (SNI). We found a beneficial effect of synaptamide on the thermal allodynia and mechanical hyperalgesia dynamics. Synaptamide prevented working and long-term memory impairment. These results are probably based on the supportive effect of synaptamide on SNI-impaired hippocampal plasticity. Nerve ligation caused microglia activation predominantly in the contralateral hippocampus, while synaptamide inhibited this effect. The treatment reversed dendritic tree degeneration, dendritic spines density reduction on CA1-pyramidal neurons, neurogenesis deterioration, and hippocampal long-term potentiation (LTP) impairment. In addition, synaptamide inhibits changes in the glutamatergic receptor expression. Thus, synaptamide has a beneficial effect on hippocampal functioning, including synaptic plasticity and hippocampus-dependent cognitive processes in neuropathic pain.

    Topics: Animals; Cognition; Ethanolamines; Hyperalgesia; Long-Term Potentiation; Male; Memory Disorders; Mice; Neuralgia; Neurogenesis; Neuronal Plasticity; Neurons

2021
    Marine drugs, 2020, Oct-15, Volume: 18, Issue:10

    Chronic neuropathic pain is a condition that causes both sensory disturbances and a variety of functional disorders, indicating the involvement of various brain structures in pain pathogenesis. One of the factors underlying chronic neuropathic pain is neuroinflammation, which is accompanied by microglial activation and pro-inflammatory factor release.

    Topics: Animals; Anti-Inflammatory Agents; Behavior, Animal; Cell Line; Constriction; Cytokines; Decapodiformes; Disease Models, Animal; Docosahexaenoic Acids; Ethanolamines; Hippocampus; Inflammation; Lipids; Male; Mice; Microglia; Neuralgia; Neurogenesis; Neurons; Rats, Wistar; Sciatic Nerve

2020